Who Owns Repligen Stock?
NASDAQ: RGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 112.64%
- Institutions (% of float)
- 118.42%
- Held by insiders
- 4.87%
- Institutional holders
- 716
- Institutions 95.1%
- Insiders 4.9%
- Public and other 0.0%
Who owns Repligen stock?
Institutional investors own about 112.6% of Repligen's shares, spread across 716 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.87% of RGEN.
The largest institutional holders are FMR, LLC (11.50%), Blackrock Inc. (8.96%) and United Capital Financial Advisors, LLC (4.36%). Together, the top 10 institutions control 47.4% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their RGEN positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RGEN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 7.35M | 11.50% | +121.0% |
| Blackrock Inc. | 5.73M | 8.96% | +6.3% |
| United Capital Financial Advisors, LLC | 2.79M | 4.36% | -0.0% |
| Vanguard Capital Management LLC | 2.44M | 3.82% | +1.3% |
| Vanguard Portfolio Management LLC | 2.27M | 3.55% | -1.8% |
| Invesco Ltd. | 2.13M | 3.34% | +53.8% |
| Price (T.Rowe) Associates Inc | 2.03M | 3.18% | +15.9% |
| Massachusetts Financial Services Co. | 2.03M | 3.17% | +25.5% |
| State Street Corporation | 1.85M | 2.89% | +2.7% |
| Ameriprise Financial, Inc. | 1.69M | 2.64% | +7.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RGEN
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 2.01M | 3.14% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.70M | 2.66% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.23M | 1.92% |
| MFS Series Trust IV-MFS Mid Cap Growth Fund | 1.04M | 1.63% |
| T. Rowe Price New Horizons Fund, Inc. | 963.03K | 1.51% |
| Fidelity Contrafund | 851.93K | 1.33% |
| AIM Counselor Series TRT -Invesco Discovery Fd. | 817.87K | 1.28% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 709.04K | 1.11% |
| SmallCap World Fund Inc | 699.73K | 1.09% |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 627.68K | 0.98% |
Frequently asked questions
Who is the largest shareholder of Repligen?
FMR, LLC is the largest institutional shareholder of RGEN, owning 11.50% of shares outstanding (7.35M shares) as of its latest 13F filing.
What percentage of Repligen is owned by institutions?
Institutions own about 112.6% of RGEN shares and 118.4% of the public float.
How much of Repligen do insiders own?
Insiders, such as officers and directors, own about 4.87% of RGEN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.